The global mammography workstation market size was estimated to be USD 158.9 million in 2023 and is expected to reach at USD 366.3 million by 2034 with a CAGR of 7.89% during the forecast period 2024-2034. The rising prevalence of breast cancer, advancements in mammography technology, greater awareness about breast cancer, a growing demand for early disease detection, an increase in new product introductions, higher FDA approvals, augmented investments in research for innovative early breast cancer detection technology, a heightened emphasis on next-generation mammography workstations, and the continuous introduction of advanced mammography workstations are some of the key factors driving market growth.
The continuous introduction of advanced mammography workstations is predicted to boost the market growth during the forecast period. A mammography workstation is a computerized device designed to assist in interpreting mammography images. It offers radiologists advanced tools for image processing and analysis, improving their capacity to identify and diagnose breast cancer. These workstations allow the visualization of mammograms in different formats, such as digital mammography and tomosynthesis, aiding in the detection of abnormalities and supporting the decision-making process for additional diagnostic measures. For instance, in December 2022, Fujifilm Healthcare Americas Corporation, a prominent provider of diagnostic and enterprise imaging solutions, unveiled the ASPIRE Cristalle mammography system featuring Digital Breast Tomosynthesis (DBT) during the annual meeting of the Radiological Society of North America (RSNA) in 2022.
By modality, multimodal was the highest revenue-grossing segment in the global mammography workstation market in 2023 owing to the widespread utilization of these devices in hospitals & breast care centers, and the continuous introduction of advanced devices. The multimodality workstation offers a high-resolution display and the capability to compare two-dimensional display and tomosynthesis images. These workstations allow for customization, enabling personalized configurations and protocols for reading. For instance, in November 2023, GE HealthCare has introduced the MyBreastAI Suite, a comprehensive platform of artificial intelligence (AI) applications designed to aid clinicians in breast cancer detection and enhance workflow productivity. Additionally, standalone is predicted to grow at the fastest CAGR during the forecast period owing to the widespread acceptance of these devices. The autonomous workstation facilitates the integration of multimodality and multivendor images. These independent workstations simplify the tasks of clinicians by streamlining intricate processes. They consolidate data from various modalities into a unified location and aid in the automatic alignment of breast tissue images. These devices offer a graphical timeline depicting patients' medical history and display digital and computed radiography on the screen.
By application, diagnosis screening was the highest revenue-grossing segment in the global mammography workstation market in 2023 owing to the significant utilization of mammography workstations in diagnostic screening, a growing number of breast screening programs, and an increase in the introduction of advanced platforms. For instance, in August 2022, Whiterabbit developed the ACT software to assist in the diagnosis of breast cancer through automated analysis of digital breast tomosynthesis images, commonly referred to as 3D mammograms. Additionally, advance imaging is predicted to grow at the fastest CAGR during the forecast period owing to the widespread adoption of these devices, marked by innovative product launches and a continuous increase in technological advancements.
By end-user, hospitals was the highest revenue-grossing segment in the global mammography workstation market in 2023 owing to the increasing frequency of breast screenings, a surge in technological advancements within mammography workstations, and a rise in healthcare funding along with various government reforms. Additionally, breast care center is predicted to grow at the fastest CAGR during the forecast period owing to the heightened awareness surrounding breast care centers, the expanding network of breast centers, and the increasing collaborations among market players. For instance, in April 2022, DetectedX and GE Healthcare have entered into an educational agreement with the aim of expanding accessibility to the Radiology Online Learning Platform, aiming to promote global excellence in diagnostic accuracy. Studies have indicated that participation in online self-assessment courses can result in a more than 34% reduction in error rates and an improvement in cancer diagnosis. These courses were specifically designed to assist radiologists in enhancing their accuracy in recognizing breast lesions in both 2D and 3D mammography.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing elderly population, a rise in the introduction of new products, ongoing technological advancements in mammography, increasing FDA approvals, and an increase in collaborative efforts among market participants. For instance, in November 2022, Google Health has disclosed its initial commercial agreement to license its AI research model for mammography, intending to incorporate it into actual clinical applications. The collaboration involves a partnership with iCAD, a company specializing in medical technology and cancer detection. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in awareness regarding the early detection of breast cancer, the increasing allocation of government funds for mammography, and the growing embrace of advanced technologies. For instance, in May 2022, Sohana Hospital in Mohali has introduced a Mobile Mammography Bus equipped with the web-based reporting system from Allengers.
The continuous introduction of advanced mammography workstations is predicted to boost the market growth during the forecast period. A mammography workstation is a computerized device designed to assist in interpreting mammography images. It offers radiologists advanced tools for image processing and analysis, improving their capacity to identify and diagnose breast cancer. These workstations allow the visualization of mammograms in different formats, such as digital mammography and tomosynthesis, aiding in the detection of abnormalities and supporting the decision-making process for additional diagnostic measures. For instance, in December 2022, Fujifilm Healthcare Americas Corporation, a prominent provider of diagnostic and enterprise imaging solutions, unveiled the ASPIRE Cristalle mammography system featuring Digital Breast Tomosynthesis (DBT) during the annual meeting of the Radiological Society of North America (RSNA) in 2022.
By modality, multimodal was the highest revenue-grossing segment in the global mammography workstation market in 2023 owing to the widespread utilization of these devices in hospitals & breast care centers, and the continuous introduction of advanced devices. The multimodality workstation offers a high-resolution display and the capability to compare two-dimensional display and tomosynthesis images. These workstations allow for customization, enabling personalized configurations and protocols for reading. For instance, in November 2023, GE HealthCare has introduced the MyBreastAI Suite, a comprehensive platform of artificial intelligence (AI) applications designed to aid clinicians in breast cancer detection and enhance workflow productivity. Additionally, standalone is predicted to grow at the fastest CAGR during the forecast period owing to the widespread acceptance of these devices. The autonomous workstation facilitates the integration of multimodality and multivendor images. These independent workstations simplify the tasks of clinicians by streamlining intricate processes. They consolidate data from various modalities into a unified location and aid in the automatic alignment of breast tissue images. These devices offer a graphical timeline depicting patients' medical history and display digital and computed radiography on the screen.
By application, diagnosis screening was the highest revenue-grossing segment in the global mammography workstation market in 2023 owing to the significant utilization of mammography workstations in diagnostic screening, a growing number of breast screening programs, and an increase in the introduction of advanced platforms. For instance, in August 2022, Whiterabbit developed the ACT software to assist in the diagnosis of breast cancer through automated analysis of digital breast tomosynthesis images, commonly referred to as 3D mammograms. Additionally, advance imaging is predicted to grow at the fastest CAGR during the forecast period owing to the widespread adoption of these devices, marked by innovative product launches and a continuous increase in technological advancements.
By end-user, hospitals was the highest revenue-grossing segment in the global mammography workstation market in 2023 owing to the increasing frequency of breast screenings, a surge in technological advancements within mammography workstations, and a rise in healthcare funding along with various government reforms. Additionally, breast care center is predicted to grow at the fastest CAGR during the forecast period owing to the heightened awareness surrounding breast care centers, the expanding network of breast centers, and the increasing collaborations among market players. For instance, in April 2022, DetectedX and GE Healthcare have entered into an educational agreement with the aim of expanding accessibility to the Radiology Online Learning Platform, aiming to promote global excellence in diagnostic accuracy. Studies have indicated that participation in online self-assessment courses can result in a more than 34% reduction in error rates and an improvement in cancer diagnosis. These courses were specifically designed to assist radiologists in enhancing their accuracy in recognizing breast lesions in both 2D and 3D mammography.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing elderly population, a rise in the introduction of new products, ongoing technological advancements in mammography, increasing FDA approvals, and an increase in collaborative efforts among market participants. For instance, in November 2022, Google Health has disclosed its initial commercial agreement to license its AI research model for mammography, intending to incorporate it into actual clinical applications. The collaboration involves a partnership with iCAD, a company specializing in medical technology and cancer detection. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in awareness regarding the early detection of breast cancer, the increasing allocation of government funds for mammography, and the growing embrace of advanced technologies. For instance, in May 2022, Sohana Hospital in Mohali has introduced a Mobile Mammography Bus equipped with the web-based reporting system from Allengers.
Segmentation: Mammography Workstation Market Report 2023 - 2034
Mammography Workstation Market Analysis & Forecast by Modality 2023 - 2034 (Revenue USD Mn)
- Standalone
- Multimodal
Mammography Workstation Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Mn)
- Clinical Review
- Advance Imaging
- Diagnostic Screening
Mammography Workstation Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Breast Care Centers
- Academia
- Hospitals
Mammography Workstation Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Mammography Workstation Market: Modality Estimates & Trend Analysis
8. Mammography Workstation Market: Application Estimates & Trend Analysis
9. Mammography Workstation Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Mammography Workstation Market
12. Europe Global Mammography Workstation Market
13. Asia Pacific Global Mammography Workstation Market
14. Latin America Global Mammography Workstation Market
15. MEA Global Mammography Workstation Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- GE Healthcare
- Hologic
- Google Health
- Fujifilm
- Philips Healthcare
- DetectedX
- Siemens Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 158.9 Million |
| Forecasted Market Value ( USD | $ 366.3 Million |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 7 |
